Aptevo Therapeutics Inc. (APVO) Total liabilities 2016–2023
Aptevo Therapeutics Inc. (APVO) total liabilities at each fiscal year-end, per SEC filings.
$16.2MFY2023 · since FY2016: $39.1M → $16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $16.2M | -70.7% |
| FY2022 | $55.4M | +49.9% |
| FY2021 | $37.0M | -11.1% |
| FY2020 | $41.6M | +12.1% |
| FY2019 | $37.1M | +6.1% |
| FY2018 | $35.0M | -15.3% |
| FY2017 | $41.3M | +5.5% |
| FY2016 | $39.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice